The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
The role of hypoxia-inducible factors in tumorigenesis
Open accessAbstract
Hypoxia-inducible factors (HIFs) are essential mediators of the cellular oxygen-signaling pathway. They are heterodimeric transcription factors consisting of an oxygen-sensitive alpha subunit (HIF-alpha) and a constitutive beta subunit (HIF-beta) that facilitate both oxygen delivery and adaptation to oxygen deprivation by regulating the expression of genes that control glucose uptake, metabolism, angiogenesis, erythropoiesis, cell proliferation, and apoptosis. In most experimental models, the HIF pathway is a positive regulator of tumor growth as its inhibition often results in tumor suppression. In clinical samples, HIF is found elevated and correlates with poor patient prognosis in a variety of cancers. In summary, HIF regulates multiple aspects of tumorigenesis, including angiogenesis, proliferation, metabolism, metastasis, differentiation, and response to radiation therapy, making it a critical regulator of the malignant phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HIF-1 also controls the expression of genes involved in tumor cell immor- talization, stem cell maintenance/de-differentiation, genetic in- stability, autocrine growth, invasion/metastasis, and treatment failure (6, 7).”
From Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth (2008) · cites this paper as [7]
Experimental — accuracy not yet measuredIn the citing paper
“Activation of HIF-1α will directly augment the transcription of genes involved in angiogenesis and metastasis, such as VEGF, MMP-9, lysyl oxidase and carbonic anhydrase IX (Rankin and Giaccia, 2008).”
From SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production (2011) · cites this paper as Rankin and Giaccia, 2008
In the citing paper
“Clinically, hypoxia is associated with HIF activation, metastasis, and resistance to chemotherapy and radiotherapy, as well as poor patient survival”
From Hypoxic control of metastasis (2016) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
Self-citationRetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“Hydroxylation of conserved proline residues within the HIF-a ODD by prolyl-4hydroxylase domain (PHD)-containing proteins mediates pVHL binding and degradation.(20,21) Under hypoxia, HIF-a subunits are stabilized and translocate to the nucleus, where they heterodimerize with ARNT and bind to HREs located within regulat…”
BackgroundIdentification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J. R., Yao, M., Duh, F.-M. C., Orcutt, M. L., Stackhouse, T. M., Kuzmin, I., Modi, W. S., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,971
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 808
Zou, J., Chu, S., Zhou, H., & Zhang, Y. (2024) · Medicine · doi:10.1097/md.0000000000037233 · Cited by 1
“[14] In various types of cancer, including breast, [15] bladder, [16] and liver hepatocellular carcinoma, [17] molecular subtypes and prognostic features have been developed based on HRG.”
BackgroundBefani, C. D., Giannouli, P., Diseri, A., Bari, A., Apostologamvrou, C., Antoniadou, C., Liakos, P., & Vafidis, D. (2024) · Journal of Food Biochemistry · doi:10.1155/2024/9278021 · Cited by 2
Drug Delivery Strategies That Target Tumors
Dong, S., Ashley, J. A., & Teng, L. (2025) · Springer eBooks · doi:10.1007/978-981-19-8930-8_3 · Cited by 1
Sen, L. T., Septyani, J., Halim, J., Santoso, B. I., Ramadhan, M. B., Syahrani, R. A., & Wanandi, S. I. (2018) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1073/3/032066 · Cited by 1
“Such a structural abnormality explains the phenomenon of hypoxia in solid tumors [5,6].”
BackgroundAn update on angiogenesis modulators with a potential therapeutic role
Philippa, C., Miroiu, R. I., SLEVIN, M. A., & Petcu, E. B. (2018) · Vascular Cell · doi:10.24238/13221-10-1-179 · Cited by 1
Bhadra, M. P., Raut, G. K., & Chakrabarti, M. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_147 · Cited by 1
Moon, E. J. (2010) · DukeSpace (Duke University) · Cited by 1
Preoperative integrated PET-CT scanning reduces the number of futile thoracotomies for lung cancer
Navani, N. (2009) · Thorax · doi:10.1136/thx.2009.127407 · Cited by 1
Wu, X. (2016) · IUScholarWorks (Indiana University) · doi:10.7912/c2s89r · Cited by 1
Gourgiotis, A., Isnard, H., Nonell, A., Aubert, M., Stadelmann, G., Dupont, E., Almahamid, I., Tiang, G., Rao, L., Lukens, W. W., et al. (2013) · Cited by 1
Hypoxia on vhl-deficient cells to obtain hif related genes through bioinformatics analysisPreprint
Lin, H., & Liu, H. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/863662 · Cited by 1
Zhao, J., Zhang, H., Liu, Y., Lu, G., Wang, Z., Mo, Q., & Jiao, L.-Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1531448/v1 · Cited by 1
Rodgers, G. M., & Gilreath, J. A. (2025) · Journal of Clinical Oncology · doi:10.1200/jco-24-02610 · Cited by 1
Mecanismes de regulació de la Lisil Oxidasa i la Fibulina-5 a nivell vascular: modulació per hipòxia
Roldán, A. G. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Hu, J. J. (2014) · DuEPublico (University of Duisburg-Essen)
Hypoxia-inducible regulatory networks and their roles in aging in C. elegans
Zhang, Y. (2009) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-180810-2696
Mechanisms of malignant and non-malignant angiogenesis using zebrafish models
Jensen, L. D. (2010) · Figshare
Oxygen-dependent Regulation of HIF-1alpha Expression and Function
Zheng, X. (2009) · Figshare
The Tumor-Suppressive Properties of Neural Stem Cells
Passino, R. (2015)
Welch, J. E. (2010) · Lund University Publications (Lund University)
Biomarkers for Prognosis and Molecularly Targeted Therapy in Renal Cell Carcinoma
Schmidt, L. S. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-615-9_11
Los «tiempos» —timing— en Neurooncología
Parera, I. C., Báez, A., Roffo, A. G., Kuchkaryan, V., Barros, J. M., Halfón, M. J., Tamborini, N. M., Larrarte, G. A., Blumenkrantz, Y., de Robles, P. A., et al. (2014) · Neurología Argentina · doi:10.1016/j.neuarg.2014.05.005
Winning, S. (2010) · DuEPublico (University of Duisburg-Essen)
Asque, E. M. (2011) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-180810-1088
“Studies have shown that this upregulation correlates with the metastatic progression due to the survival (resistance to cancer therapies) of primary tumor cells (Maxwell et al. 2001; Dewan et al. 2006; Chan and Giaccia 2007; Rankin and Giaccia 2008).”
BackgroundMOLECULAR ASPECTS OF ENDOTHELIAL CELL FUNCTION AND HYPOXIA-DEPENDENT TUMOR ANGIOGENESIS
Kucharzewska, P. (2011)
Fardin, P., Barla, A., Mosci, S., Rosasco, L., Verri, A., Versteeg, R., Caron, H. N., Molenaar, J. J., Øra, I., Eva, A., et al. (2010)
Disulfide bond formation - the missing link between the HR and the UPR?
Luukas, M. J. (2011)
Hypoxia-Inducible Factor: A New Hope to Counteract Stroke
Chen, C., & Zhou, C. (2012) · Springer eBooks · doi:10.1007/978-1-4419-9530-8_8
“To date, three HIFs (HIF-1, -2, and -3) have been identifi ed to regulate transcriptional process in response to low oxygen levels [ 38 ] .”
BackgroundWang, T., Yun, S. J., & Xu, X. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3554-3_1
Role of angiopoietin-like 4 in tumor growth.
Zhu, P. (2011) · doi:10.32657/10356/46431
Poderoso, J. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-45865-6_26
Schwock, J. (2010) · TSpace (University of Toronto)
Hadi‐Alijanvand, H., Proctor, E. A., Goliaei, B., Dokholyan, N. V., & Moosavi‐Movahedi, A. A. (2013) · PLoS ONE · doi:10.1371/annotation/c414c3ec-b64e-4cf4-bff2-7bb7b3abb558
Inhibition of Breast Cancer Angiogenesis and Metastasis ay Targeting Hypoxia-Inducible Factor-1α
Madu, C. O. (2012) · doi:10.21007/etd.cghs.2012.0192
“HIF-1 binds to the HRE DNA center recognition sequence (5′-RCGTG-3′), and plays a central role in tumor progression through the initiation and regulation of the transcription of a number of genes essential for tumor adaptation to hypoxia and has been implicated in major aspects of cancer biology, including immortaliza…”
BackgroundGreim, H. A., Hartwig, A., & MAK Commission (2016) · Wiley eBooks · doi:10.1002/3527600418.mbphaeoe4916
Zheng, W., & Teegarden, D. (2013) · CRC Press eBooks · doi:10.1201/b15413-3
Park, Y.-G., Choi, J., Song, I. K., Jackson, C., Park, S., & Seol, J. (2017) · Sains Malaysiana · doi:10.17576/jsm-2017-4610-28
“HIFs principally drive the cellular response under hypoxia, through interaction with hypoxia-responsive elements that leads to gene expression (Rankin & Giaccia 2008).”
BackgroundChoo, A. (2017) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · doi:10.4225/55/5850cd986b1cb
“adaptive response to mediate tumour cell survival in the initial stages of tumourigenesis, however prolonged autophagy can result in cell death (Rankin and Giaccia, 2008; Yang et al., 2011).”
BackgroundTHE ROLE OF N6-METHYLADENOSINE IN HYPOXIA AND CELLULAR TRANSFORMATION
Fry, N. J. (2017) · The Scholarship East Carolina University's Institutional Repository (East Carolina University)
HIF1α: A Key Emerging Player in Pancreatic Cancer
Padmavathi, I. J. N., Ramaneswari, K., & Reddy, A. M. (2017) · Springer eBooks · doi:10.1007/978-981-10-6728-0_26
Saad, M. (2019) · uO Research (University of Ottawa) · doi:10.20381/ruor-23661
Selenium modulation of gut epithelial cell stress responses
Moore, A. N. (2017)
Butcher, K. (2019) · Wolverhampton Intellectual Repository and E-Theses (University of Wolverhampton)
The Role of HIF-1α in Hepatocellular Carcinoma
Momin, S., & Nagaraju, G. P. (2020) · Diagnostics and therapeutic advances in GI malignancies · doi:10.1007/978-981-15-5471-1_15
Gayyed, M. F., Soliman, M. M., Anwer, A. Z. M., Tawfiek, E. R., & El-Maqsoud, N. M. R. A. (2020) · Saudi Journal of Pathology and Microbiology · doi:10.36348/sjpm.2020.v05i12.002
“HIFs (the hypoxia-inducible factors) mediate the effect of hypoxia on tumor cells [3, 4].”
BackgroundWu, Y., XuYayan, G., Gong, Z., & Yang, Z. L. (2014)
Visagie, M. H. (2014) · UpSpace Institutional Repository (University of Pretoria)
Bhadra, M. P., Raut, G. K., & Chakrabarti, M. (2021) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_147-1
7267 函館市西部地区の町並み景観の変貌とその要因に関する研究 : -経年的追跡調査による- 2. 変貌の要因と景観誘導の可能性
森下, 満., 足達, 富., 野口, 孝., & 山下, 圭. (1992) · 学術講演梗概集. F, 都市計画, 建築経済・住宅問題, 建築歴史・意匠
Phäochromozytome [MAK Value Documentation in German language, 2010]
Arbeitsstoffe, D. F. S. S. Z. P. G., & Hartwig, A. (2012) · Wiley eBooks · doi:10.1002/3527600418.mbphaeod0049
Lipton, S. A., & Digicaylioglu, M. H. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732224019.793549201
Kumavath, R., & Pavithran, H. (2022) · Research Square · doi:10.21203/rs.3.rs-2361555/v1
Lu, X., Yan, C. H., Yuan, M., Wei, Y., Hu, G., & Kang, Y. (2023) · doi:10.1158/0008-5472.c.6500217
Lu, X., Yan, C. H., Yuan, M., Wei, Y., Hu, G., & Kang, Y. (2023) · doi:10.1158/0008-5472.c.6500217.v1
Bodily, J. M., Mehta, K. P. M., & Laimins, L. A. (2023) · doi:10.1158/0008-5472.c.6502997.v1
Yu, B., Miao, Z., Jiang, Y. H., Li, M.-H., Yang, N., Li, T., & Ding, J. (2023) · doi:10.1158/0008-5472.c.6499152.v1
Aryee, D. N. T., Niedan, S., Kauer, M. O., Schwentner, R., Bennani-Baı̈ti, I. M., Ban, J., Muehlbacher, K., Kreppel, M., Walker, R. L., Meltzer, P. S., et al. (2023) · doi:10.1158/0008-5472.c.6500114.v1
Data from Differential Hypoxic Regulation of Hypoxia-Inducible Factors 1α and 2α
Lin, Q., Cong, X., & Yun, Z. (2023) · doi:10.1158/1541-7786.c.6542202
Anaz, A. A., Suryaprakash, R. T. C., Shearston, K., & Kujan, O. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815080384123010008
HIF-1α gene/protein and oxidative stress in patients with colorectal cancer: A pilot study
Akbar, S., Fazeli, M. S., Hemmati, R., Pirzadeh, M., Seyedan, S. M., Ferns, G. A., Pakzad, R., Yazdanian, Z., & Mobarra, N. (2023) · Gene Reports · doi:10.1016/j.genrep.2023.101783
Untersuchung der pharmakologischen Modulation von ARNT-Homodimeren auf die Renoprotektion
Rapp, G. C. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10120
In-droplet multiplex immunoassays for hypoxia-induced single-cell cytokines
Cong, L., Guo, X., Wang, J., Meng, F., Zhao, J., Xu, W., Shi, W., Liang, C., Shi, Z., & Xu, S. (2024) · Talanta · doi:10.1016/j.talanta.2024.126548
Gang, N., van Allen, K. A., Willmore, W. G., Lynn, F. C., & Bruin, J. E. (2024) · bioRxiv · doi:10.1101/2024.09.25.615065
Li, Z., Yin, B., Xu, Y., Wang, C., Li, X., Lu, S., Ke, S., Qian, B., Yu, H., Bai, M., et al. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000567
Clinical and Prognostic Value of VHL in Korean Patients with Rectal Cancer
Moon, S.-W., Lee, J.-C., Lee, J., Kim, T.-Y., & Park, J. H. (2025) · Medicina · doi:10.3390/medicina61020306
“The loss of VHL gene expression is commonly associated with CRC progression and poor prognosis [24,25].”
Ray, S. K., & Mukherjee, S. (2025) · Springer eBooks · doi:10.1007/978-981-96-1016-7_7
Erol, Z., Rugji, J., Aydoğan, A., Özmen, Ö., & Taşçı, F. (2025) · Veterinary Medicine and Science · doi:10.1002/vms3.70535
EPAS1 regulates host antibacterial defense in response to bacterial quorum sensingPreprint
Li, H., Kong, X., Cui, B., Li, X., Li, X., Wang, M., Wang, L.-E., Chen, X., Qian, W., Zhang, L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.09.681351
RORγ Hijacks HIF1α to Promote Peritoneal Metastasis of Gastric Cancer
Wang, Q., Zhong, L., Wang, X., Zhang, Z., Cai, G., Gu, Z., Yang, B., Zhou, H., Li, H., Chan, F. L., et al. (2026) · Cancer Research · doi:10.1158/0008-5472.can-25-1690
Liu, Y., Jiang, B., Xia, L., Bao, E., Wang, L., & Zhu, P.-Y. (2025) · Nature and Science of Sleep · doi:10.2147/nss.s496540
“4,5 However, the relationship between OSA and prostate cancer remains unclear, with conflicting results reported in the literature.”
Zargar, M., Anvari, A. H., Abbasian, M. H., Alipour, A. H., Shirkoohi, R., & Ganji, S. M. (2025) · Gene Reports · doi:10.1016/j.genrep.2025.102395
Vorrink, S. U. (2014) · doi:10.17077/etd.snp8ku85
“cells often show elevated levels of HIF-1α and HIF-2α as well (Rankin and Giaccia, 2008).”
InfluentialRolle der Transkription und Aktivität von MIA ("Melanoma Inhibitory Activity") im malignen Melanom
Winklmeier, A. (2009) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.12311
Dolprasit, C., Settheetham‐Ishida, W., Natphopsuk, S., Tiwawech, D., & Settheetham, D. (2013) · Srinagarind Medical Journal (SMJ) - ศรีนครินทร์เวชสาร
Kharrati-Koopaee, H., Ebrahimie, E., Dadpasand, M., Niazi, A., Tian, R., & Esmailizadeh, A. (2021) · Figshare · doi:10.6084/m9.figshare.14936331
Kharrati-Koopaee, H., Ebrahimie, E., Dadpasand, M., Niazi, A., Tian, R., & Esmailizadeh, A. (2021) · Figshare · doi:10.6084/m9.figshare.14936334
Wang, S., Cai, Y., Qingjie, F., Gao, J., & Teng, B. (2021) · Figshare · doi:10.6084/m9.figshare.15020768
Mohammed H. Assi, S. A. E. (2018) · International Journal of Biosciences (IJB) · doi:10.12692/ijb/13.4.387-395
Wang, X., Guo, J., Zhang, R., Dong, Y., Hao, L., Chen, B., Xu, H., Ma, Y., & Pang, K. (2026) · Scientific Reports · doi:10.1038/s41598-026-39635-9
“While some studies link its overexpression to increased tumor aggressiveness 15 , others suggest it may exert paradoxical tumor-suppressive effects through specific signaling axes 16 .”
Tian, D., & Tang, J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40578-5.00011-8
Guerrab, A. E. (2011) · theses.fr (ABES) · doi:10.70675/0680d6aez5ddfz48efzabe9zf58f93e15842
Les plasmas froids, nouvelle stratégie thérapeutique en cancérologie
Vandamme, M. (2012) · theses.fr (ABES) · doi:10.70675/6c208bb1zfa66z4b33z8b69z39f1f07a523f
“Page 18 l’interaction de HIF-1α avec son coactivateur CBP/p300 et prévenant l’expre ssion de ses gènes cibles [39].”
Métastases cérébrales et hypoxie : approches pré-cliniques in vitro et in vivo en imagerie TEP/IRM
Fantin, J. (2023) · theses.fr (ABES) · doi:10.70675/17c3d7d3zde37z4e93z9446zc690e62f8a7a
Bharti, N., Sureka, S. K., Singh, U. P., Gupta, O., & Rao, R. N. (2026) · BMJ Case Reports · doi:10.1136/bcr-2025-270527
“The JKCVHL report similarly documented variable clinical manifestations, tumour multiplicity and outcomes in VHL-associated RCC. 11 These data affirm that patient-specific factors—including mutation subtype, growth kinetics and histological grade—contribute significantly to prognosis.”
InfluentialLung cancer location drives lateralized ventilation loss and adverse outcome
Yu, K., Wang, H., Li, C., Cheng, B., Zheng, X., Chen, P., Fu, W., He, J., & Liang, W. (2026) · Respiratory Medicine · doi:10.1016/j.rmed.2026.108956
Using Organoids to Unlock the Potential of Human Torpor for Spaceflight
Diaz, J., Maxwell, J. T., Wilson, P. F., Jacobson, A. R., Atala, A., Almeida-Porada, G. D., & Porada, C. D. (2026) · Current Stem Cell Reports · doi:10.1007/s40778-026-00257-6
Uniyal, P., & Raina, D. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-10834-1
“Hypoxia in tumors is mediated by a key player called Hypoxia-Inducible Factors (HIFs) [ 5].”
Kim, K. S., Kim, Y., Shin, K., Paing, A. S., Baek, S., Hong, B., & Lim, C. (2026) · Medicina · doi:10.3390/medicina62071267
“Approximately 50–60% of rapidly growing solid tumors contain hypoxic regions, in which the HIF pathway promotes angiogenesis, metastasis, proliferation, and treatment resistance [23,24].”
Chen, Y., Zhuang, J., Yu, H., Li, K., Zhang, Y., Sun, H., Jiang, L., Yang, Z., Bai, K., Tao, Y., et al. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112723
Liu, Y., Zhang, M., Ge, X., & Meng, X. (2026) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2026.109662
Metadata
- Authors
- Rankin, E. B., & Giaccia, A. J.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Giaccia, A J
- Venue
- Cell Death & Differentiation
- Published
- 2008-02-15
- Volume
- 15
- Issue
- 4
- Pages
- 678-685
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- PMC
- PMC3050610
- OpenAlex
- W2014245338
- Cited by
- 806
- References
- 105
- Citations by year
- 2026: 18 · 2025: 24 · 2024: 30 · 2023: 34 · 2022: 43 · 2021: 42 · 2020: 39 · 2019: 38 · 2018: 33 · 2017: 44 · 2016: 45 · 2015: 48 · 2014: 56 · 2013: 51 · 2012: 46
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cell Death and Differentiation (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (P01CA067166, T32CA009151)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- hypoxia-inducible factor, carcinogenesis, oxygen signaling, hypoxia-inducible factor alpha, angiogenesis, cancer metabolism, tumor growth, metastasis, radiation response, tumor differentiation, prognosis, apoptosis, cell proliferation
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Adaptation, Physiological, Animals, Hypoxia, Cell Differentiation, Energy Metabolism, Humans, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Oxygen, Signal Transduction, Cell Hypoxia, Cell Proliferation, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review